Question 1

Does Quadrature Capital own IBRX stock?

Accepted Answer

No. Quadrature Capital exited its IBRX (Immunitybio) position in Q1 2026. Its Q4 2025 13F listed 436,869 shares worth $865,001.

Question 2

How many shares of IBRX does Quadrature Capital own?

Accepted Answer

None since Q1 2026, when Quadrature Capital exited the position. Its Q4 2025 13F listed 436,869 shares worth $865,001.

Question 3

What is Quadrature Capital's IBRX position worth?

Accepted Answer

Quadrature Capital's IBRX position was worth $865,001 in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is Quadrature Capital buying or selling IBRX?

Accepted Answer

In Q1 2026, Quadrature Capital exited its entire IBRX position.

Question 5

When did Quadrature Capital first buy IBRX?

Accepted Answer

Quadrature Capital first reported IBRX in its Q3 2025 13F and listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$7.67	0
2025-Q4	Increased	436,869	+66.5%	$865,001	0.0%	$1.98	37
2025-Q3	New	262,391	—	$642,858	0.0%	$2.46	34